Hikma Pharmaceuticals (HKMPY)
PNK: HKMPY
· Real-Time Price · USD
52.97
0.00 (0.00%)
At close: Apr 30, 2025, 3:45 PM
0.00% (1D)
| Bid | 51.75 |
| Market Cap | 5.86B |
| Revenue (ttm) | 3.11B |
| Net Income (ttm) | 357.66M |
| EPS (ttm) | 3.22 |
| PE Ratio (ttm) | 16.45 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | 55.77 |
| Volume | 100 |
| Avg. Volume (20D) | 390 |
| Open | 47.08 |
| Previous Close | 52.97 |
| Day's Range | 47.08 - 52.97 |
| 52-Week Range | 45.97 - 59.26 |
| Beta | 0.69 |
About HKMPY
Hikma Pharmaceuticals PLC develops, manufactures, markets, and sells a range of generic, branded, and in-licensed pharmaceutical products. The company offers its products in solid, semi-solid, liquid, and injectable final dosage forms. It operates through three segments: Injectables, Generics, and Branded. The Injectables segment provides generic injectable products primarily for use in hospitals. The Generics segment offers oral and other non-in...
Sector Healthcare
IPO Date Feb 7, 2012
Employees 9,500
Stock Exchange PNK
Ticker Symbol HKMPY
Website https://www.hikma.com
2 months ago · seekingalpha.com
Hikma Pharmaceuticals PLC (HKMPF) Q4 2024 Earnings Call Pre-Recorded (Transcript)Hikma Pharmaceuticals PLC (OTCPK:HKMPF) Q4 2024 Results Conference Call February 26, 2025 2:00 AM ET Company Participants Riad Mishlawi - Chief Executive Officer Khalid Nabilsi - Chief Financial Offic...